{"id":"menopur-ferring","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Injection site reactions (pain, bruising, redness)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Abdominal pain or bloating"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL415606","moleculeType":"Protein","molecularWeight":"1632.29"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Menopur contains equal amounts of FSH and LH extracted from the urine of postmenopausal women. FSH directly stimulates follicle growth and estrogen production in the ovaries, while LH supports follicle maturation and triggers ovulation. This combination mimics the natural hormonal environment needed for controlled ovarian stimulation in assisted reproductive procedures.","oneSentence":"Menopur is a purified preparation of human menopausal gonadotropins (hMG) containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and hormone production.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:54:20.915Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles"},{"name":"Ovulation induction in anovulatory women"}]},"trialDetails":[{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT05370794","phase":"","title":"Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-04-19","conditions":"In Vitro Maturation of Oocytes","enrollment":35},{"nctId":"NCT04416607","phase":"NA","title":"Corifollitropin Alpha and Ovarian Response","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2018-06-15","conditions":"Infertility, Female","enrollment":300},{"nctId":"NCT02673632","phase":"","title":"The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2016-02","conditions":"Infertility","enrollment":30},{"nctId":"NCT02412904","phase":"PHASE4","title":"Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2014-01","conditions":"Infertility","enrollment":188},{"nctId":"NCT00820482","phase":"PHASE4","title":"Comparing Highly Purified hMG With Recombinant FSH + Recombinant LH in Women Undergoing Intrauterine Insemination.","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2009-01","conditions":"Ovarian Stimulation Preceding Intrauterine Insemination","enrollment":80}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":60,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Menopur®, Ferring","genericName":"Menopur®, Ferring","companyName":"Instituto Valenciano de Infertilidad, IVI VALENCIA","companyId":"instituto-valenciano-de-infertilidad-ivi-valencia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Menopur is a purified preparation of human menopausal gonadotropins (hMG) containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and hormone production. Used for Controlled ovarian hyperstimulation in assisted reproductive technology (ART) cycles, Ovulation induction in anovulatory women.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}